US Stock MarketDetailed Quotes
MRVI Maravai LifeSciences
- 5.150
- -0.140-2.65%
Trading Nov 26 13:49 ET
730.49MMarket Cap-3083P/E (TTM)
5.250High4.960Low961.79KVolume5.250Open5.290Pre Close4.85MTurnover0.98%Turnover RatioLossP/E (Static)141.84MShares11.55552wk High2.12P/B506.31MFloat Cap4.27552wk Low--Dividend TTM98.31MShs Float63.550Historical High--Div YieldTTM5.48%Amplitude4.275Historical Low5.046Avg Price1Lot Size
Maravai LifeSciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.49%65.2M | 6.51%73.4M | -18.79%64.18M | -67.28%288.95M | -63.78%74.14M | -65.04%66.87M | -71.61%68.91M | -67.65%79.03M | 10.48%883M | -10.39%204.71M |
| Operating revenue | -2.49%65.2M | 6.51%73.4M | -18.79%64.18M | -67.28%288.95M | -63.78%74.14M | -65.04%66.87M | -71.61%68.91M | -67.65%79.03M | 10.48%883M | -10.39%204.71M |
| Cost of revenue | 0.38%36.83M | -11.56%38.27M | 13.83%38.34M | -11.96%148.74M | -34.07%35.11M | -3.90%36.69M | 15.41%43.27M | -15.88%33.68M | 20.20%168.96M | 36.06%53.25M |
| Gross profit | -5.98%28.37M | 37.00%35.13M | -43.01%25.84M | -80.37%140.2M | -74.23%39.03M | -80.29%30.18M | -87.51%25.64M | -77.80%45.35M | 8.41%714.04M | -19.99%151.46M |
| Operating expense | 0.51%43.43M | 15.84%45.84M | 7.24%45.92M | 14.25%168.67M | 2.03%43.07M | 19.42%43.21M | 22.38%39.57M | 16.05%42.82M | 28.06%147.63M | 21.43%42.21M |
| Selling and administrative expenses | 0.57%39.09M | 14.64%40.56M | 5.73%40.89M | 17.12%151.39M | 3.43%38.48M | 26.20%38.86M | 26.07%35.38M | 16.48%38.67M | 29.18%129.26M | 45.43%37.2M |
| Research and development costs | -0.07%4.34M | 25.99%5.28M | 21.40%5.03M | -5.93%17.28M | -8.32%4.59M | -19.34%4.35M | -1.87%4.19M | 12.18%4.15M | 20.70%18.37M | -45.44%5.01M |
| Operating profit | -15.54%-15.06M | 23.11%-10.71M | -892.46%-20.07M | -105.03%-28.47M | -103.70%-4.04M | -111.15%-13.03M | -108.06%-13.93M | -98.49%2.53M | 4.24%566.42M | -29.31%109.25M |
| Net non-operating interest income expense | -56.08%-6.56M | -2,000.87%-4.85M | 36.87%-3.65M | -0.49%-18.17M | -1.26%-7.94M | -34.09%-4.21M | 94.79%-231K | -117.27%-5.79M | 40.26%-18.08M | -11.68%-7.84M |
| Non-operating interest income | -4.86%7.07M | 4.34%7.09M | 19.27%7.21M | 1,085.93%27.73M | 219.03%7.46M | --7.43M | --6.79M | --6.05M | --2.34M | --2.34M |
| Non-operating interest expense | 17.16%13.63M | 70.02%11.94M | -8.19%10.86M | 124.81%45.89M | 51.28%15.4M | 271.08%11.64M | 58.37%7.02M | 344.18%11.83M | -32.54%20.41M | 44.97%10.18M |
| Other net income (expense) | -4,530.91%-154.02M | -271.02%-1.36M | 203.94%1.32M | 21,112.29%664.37M | 12,186.94%668.17M | -83,050.00%-3.33M | -87.79%797K | -159.28%-1.27M | -82.23%3.13M | -95.34%-5.53M |
| Special income (charges) | -6,359.41%-154.06M | -48.23%1.2M | --1.21M | -141.89%-3.18M | ---3.11M | ---2.39M | -70.31%2.32M | --0 | -32.51%7.59M | --0 |
| -Less：Restructuring and merger&acquisition | -107.63%-182K | 48.23%-1.2M | ---1.21M | 140.77%3.18M | --3.11M | --2.39M | 70.31%-2.32M | --0 | ---7.8M | --0 |
| -Less:Impairment of capital assets | --154.24M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --208K | --0 |
| -Gain on sale of business | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non- operating income (expenses) | 103.51%33K | -68.66%-2.56M | 108.36%106K | 15,067.47%667.55M | 12,243.22%671.28M | -23,425.00%-941K | -19.14%-1.52M | -154.03%-1.27M | -169.91%-4.46M | -95.34%-5.53M |
| Income before tax | -754.17%-175.64M | -26.66%-16.93M | -395.45%-22.41M | 12.02%617.74M | 584.41%656.19M | -118.08%-20.56M | -107.64%-13.36M | -102.71%-4.52M | 3.90%551.47M | -33.74%95.88M |
| Income tax | 105.69%311K | -71.36%-2.44M | 108.54%271K | 1,143.42%756.11M | 8,970.30%766.17M | -138.70%-5.46M | -107.78%-1.42M | -115.89%-3.18M | -1.15%60.81M | -51.95%8.45M |
| Net income | -1,065.11%-175.96M | -21.34%-14.49M | -1,582.49%-22.68M | -128.20%-138.38M | -225.80%-109.98M | -115.15%-15.1M | -107.62%-11.94M | -100.92%-1.35M | 4.56%490.66M | -31.22%87.43M |
| Net income continuous Operations | -1,065.11%-175.96M | -21.34%-14.49M | -1,582.49%-22.68M | -128.20%-138.38M | -225.80%-109.98M | -115.15%-15.1M | -107.62%-11.94M | -100.92%-1.35M | 4.56%490.66M | -31.22%87.43M |
| Minority interest income | -790.24%-76.92M | -27.86%-6.91M | -727.63%-10.6M | -107.15%-19.35M | -108.08%-4.02M | -115.66%-8.64M | -106.32%-5.4M | -101.60%-1.28M | -5.83%270.46M | -30.14%49.8M |
| Net income attributable to the parent company | -1,432.62%-99.04M | -15.96%-7.59M | -17,926.87%-12.08M | -154.05%-119.03M | -381.55%-105.96M | -114.53%-6.46M | -109.18%-6.54M | -100.10%-67K | 20.97%220.21M | -32.59%37.63M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -1,432.62%-99.04M | -15.96%-7.59M | -17,926.87%-12.08M | -154.05%-119.03M | -381.55%-105.96M | -114.53%-6.46M | -109.18%-6.54M | -100.10%-67K | 20.97%220.21M | -32.59%37.63M |
| Basic earnings per share | -1,300.00%-0.7 | 0.00%-0.05 | -17,581.73%-0.09 | -153.89%-0.9 | -385.71%-0.8 | -114.71%-0.05 | -109.26%-0.05 | -100.10%-0.0005 | 5.03%1.67 | -33.33%0.28 |
| Diluted earnings per share | -1,300.00%-0.7 | 0.00%-0.05 | -17,581.73%-0.09 | -153.89%-0.9 | -385.71%-0.8 | -114.71%-0.05 | -109.43%-0.05 | -100.10%-0.0005 | 7.05%1.67 | -33.33%0.28 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data